()
 

Overview

Barr Pharmaceuticals, Inc. is a global specialty pharmaceutical company that operates in more than 30 countries worldwide and is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients. A holding company, Barr operates through its principal subsidiaries: Barr Laboratories, Inc., Duramed Pharmaceuticals, Inc. and PLIVA d.d. and its subsidiaries. The Barr Group of companies markets more than 115 generic and 25 proprietary products in the U.S. and more than 1,200 products globally outside of the U.S. For more information, visit www.barrlabs.com.

Contact Information

400 Chestnut Ridge Road
Woodcliff Lake, NJ 07677-7668

tel: 201-930-3300
fax: 845-354-0504
http://www.barrlabs.com

,  



Investor Relations



tel:
fax:




Stock

Exchange: NYSE
Industry: Drugs - Generic
Market Cap: $4.5B




 
The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.